Trimel Pharmaceuticals Corporation (TSX: TRL) announced today that the United States Food and Drug Administration (FDA) has approved Natesto™ (testosterone), formerly CompleoTRT™, to treat men with low testosterone.

Dr. Reddy’s Laboratories announced today that is has launched f inasteride tablets (1 mg), a bioequivalent generic version of Propecia ® ( finasteride ) tablets in the US market on January 02, 2013. Dr. Reddy’s ANDA for f inasteride 1 mg Tablets has been awarded a 180-day period of marketing exclusivity in the US on 2 Jan, 2013.